The Allergen Detection Kit segmentation by application isolates four primary end‑use domains that together drive the market’s revenue distribution. Food & Beverage accounts for the largest share, as manufacturers of processed foods, restaurants, and catering services must comply with stringent labeling regulations; this segment generates roughly 55 % of total sales, reflecting both high volume testing and recurring kit purchases. Pharmaceutical users employ kits to verify the absence of allergenic residues in drug excipients and biologics, contributing about 20 % of the market due to the premium pricing of validated assays. Clinical Diagnostics laboratories adopt kits for patient‑level allergen screening, representing 15 % of revenue, a proportion that is expanding with increased awareness of food‑related adverse events. Finally, Research & Development entities, including academic and contract research organizations, purchase kits for method development and validation, accounting for the remaining 10 %. Collectively, these application categories shape the overall market size by allocating resources, influencing product innovation, and dictating pricing dynamics.